The Life Science and Healthcare Sector Group focuses on providing long-term professional legal services and support to institutions in the life science and healthcare sector. Our business covers the following areas:

1. Pharmaceuticals

• Enterprise compliance and specialized services, including regulatory compliance services for the research and development of drugs and medical devices, IND, clinical trials, NDA and product registration; compliance review of production, operation management, business models, donation sponsorship plans and marketing plans; compliance and privacy protection of medical data, “data element X medical technology innovation”, medical data asset collection and compilation, medical data asset investment, medical data asset operation; anti-commercial bribery training and criminal compliance system building; antitrust risk analysis and assessment; advertising compliance; product liability.

• Investment and M&A, listing, bankruptcy and restructuring, including investment and M&A, listing, and other aspects of the entire industry chain; domestic and cross-border technology licensing and transfer (MAH changes), transfer of pharmaceutical commercialization rights; investment and financing of pharmaceutical projects; overseas acquisitions of pharmaceutical companies.

• Intellectual property protection, including patent application, structuring, monitoring operation and protection for pharmaceutical and medical device companies; protection of trade secrets in pharmaceutical and healthcare technology; trademark application, structuring, monitoring, operation and protection for pharmaceutical device companies; transformation of patents, scientific and technological achievements of healthcare and scientific research institutions; strategic assessment and management of patent portfolios, FTO analysis.

• Dispute resolution, litigation and arbitration, including disputes over pharmaceutical investments, equity disputes; other contract disputes; intellectual property infringement disputes; early resolution mechanisms for pharmaceutical patent disputes; product liability disputes; disputes over adverse events in clinical trials; administrative review and litigation.

2. Healthcare

• “Data element X healthcare”, compliance and privacy protection of healthcare data, healthcare data assets collection and compilation, healthcare data assets investment, operation of healthcare data assets; market access and transaction structure of healthcare sector; investment and M&A of healthcare, elderly care, and rehabilitation institutions; investment and financing, and entrusted management of non-public hospitals; compliance management of medical groups, medical treatment combination, medical communities, and internet hospitals;

• Public hospital cooperation with external third parties, building of risk prevention and compliance system, investment, financing, M&A, equity transfers, and perennial legal services for medical institutions;

• Transformation of patents and scientific and technological achievements of medical institutions; protection of intellectual property and trade secret; application of medical technology; management of clinical trials;

• Building of criminal compliance system, training on anti-commercial bribery; analysis and assessment of antitrust risk; compliance of medical advertising; medical safety control; dispute resolution over hospital operation and medical disputes.